Fasciola hepatica Fatty Acid Binding Protein 1 modulates T cell polarization by promoting dendritic cell thrombospondin-1 secretion without affecting metabolic homeostasis in obese mice
Ontology highlight
ABSTRACT: The immunomodulatory effects of recombinant F. hepatica FABP1 (fhFABP1) on monocyte-derived human DCs (moDCs) and the underlying mechanism were investigated using various approaches, including DC-allogenic T cell co-culture and DC phenotyping through transcriptomic, proteomic and FACS analyses. We found that fhFABP1 induced a tolerogenic-like phenotype in LPS-stimulated moDCs characterized by a dose-dependent increase in the cell-surface tolerogenic marker CD103 and IL-10 secretion, while DC co-stimulatory markers were not affected. A significant decrease in secretion of the pro-inflammatory cytokines IL-12p70 and IL-6 was also observed. In addition, these effects were associated with an increase in both Th2-on-Th1 ratio and IL-10 secretion by CD4+ T cells following DC-T cell co-culture. RNA sequencing and targeted proteomic analyses identified thrombospondin-1 (TSP-1) as a non-canonical factor highly expressed and secreted by fhFABP1-primed moDCs. The effect of fhFABP1 on T cell skewing was abolished when using an TSP-1 blocking antibody during DC-T cell co-culture. Immunomodulation by helminth molecules has also been linked to improved metabolic homeostasis during obesity. In vivo, although fhFABP1 injection in high-fat diet-fed obese mice induced a potent Th2 immune response in adipose tissue, it did not improved insulin sensitivity or glucose homeostasis.
ORGANISM(S): Homo sapiens
PROVIDER: GSE197462 | GEO | 2022/06/22
REPOSITORIES: GEO
ACCESS DATA